Internal Medicine, Rheumatology · Little River, SC
NPI
1639467152
Since 2011
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
3980 Highway 9 E Ste 340
Little River, SC, 29566
Phone (843) 366-3040
Groups this clinician bills Medicare through
Medicare paid, 2024
$109K
1,906 services
Medicare patients, 2024
746
Average age 73
Drug cost, 2024
$3.5M
6,254 prescriptions
Company payments, 2025
$1,031
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pinky S Vaidya was code 99214 (office e&m - established), 698 times for 371 patients. In total Pinky S Vaidya billed 1,906 services in 12 codes, and Medicare paid $109K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-02-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 698 | 371 | $80.84 | $56K |
| 99213 Office E&M - Established | Office | 575 | 423 | $54.75 | $31K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 304 | 65 | $0.72 | $218 |
| 20600 Joint Injection | Office | 73 | 29 | $30.20 | $2,205 |
| 20610 Joint Injection | Office | 72 | 45 | $39.45 | $2,840 |
| 99204 Office E&M - New | Office | 71 | 71 | $110.55 | $7,849 |
| 99203 Office E&M - New | Office | 59 | 59 | $62.83 | $3,707 |
| 99215 Office E&M - Established | Office | 24 | 23 | $115.24 | $2,766 |
By year: 2022 $111K for 1,506 services; 2023 $95K for 1,560 services; 2024 $109K for 1,906 services.
Medicare prescription drug claims, 2024
In 2024, the drug Pinky S Vaidya prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 786 prescriptions and refills. In total Pinky S Vaidya wrote 6,254 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 786 | 1,755 | 225 | $30K |
| Methotrexate Methotrexate Sodium | 772 | 1,127 | 147 | $15K |
| Gabapentin Generic | 631 | 1,038 | 148 | $8,401 |
| Prednisone Generic | 571 | 693 | 138 | $3,074 |
| Duloxetine Hcl Generic | 564 | 1,081 | 141 | $13K |
| Diclofenac Sodium Generic | 274 | 459 | 83 | $4,013 |
| Pregabalin Generic | 254 | 367 | 49 | $5,429 |
| Cyclobenzaprine Hcl Generic | 248 | 283 | 57 | $1,840 |
| Methylprednisolone Generic | 238 | 238 | 182 | $1,509 |
| Leflunomide Generic | 233 | 490 | 61 | $13K |
| Celecoxib Generic | 170 | 313 | 50 | $4,726 |
| Allopurinol Generic | 138 | 302 | 41 | $1,342 |
| Enbrel Sureclick Etanercept | 86 | 95 | 11 | $751K |
| Tizanidine Hcl Generic | 70 | 108 | 29 | $440 |
| Alendronate Sodium Generic | 68 | 158 | 25 | $561 |
Brand drugs: 592 claims; generic drugs: 5,648 claims; opioid claims: 25.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pinky S Vaidya $1,031 ($1,031 in general payments such as food, travel and fees) from 11 companies. The largest payer was Amgen Inc. with $244.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 14 | $244 |
| Abbvie Inc. ABBV | 9 | $190 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $151 |
| Janssen Biotech, Inc. JNJ | 6 | $147 |
| Radius Health, Inc. | 4 | $91.88 |
| UCB, Inc. UCB.BR | 2 | $54.06 |
| Pfizer Inc. PFE | 2 | $49.79 |
| GlaxoSmithKline, LLC. GSK | 2 | $49.23 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $23.3 |
| Scilex Pharmaceuticals Inc. | 1 | $16.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.